We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Heiq Plc | LSE:HEIQ | London | Ordinary Share | GB00BN2CJ299 | ORD GBP0.05 |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 4.50 | 0.00 | 00:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 4.50 | 5.50 | ||||
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Finance Services | 62.32M | -20.84M | -0.1236 | -0.36 | 7.58M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 4.50 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 19/11/2024 | 08:00 | UK RNS | London Stock Exchange Notice Cancellation - HEIQ PLC |
| 18/11/2024 | 07:00 | UK RNS | HeiQ PLC Director/PDMR Shareholding |
| 14/11/2024 | 14:28 | ALNC |  HeiQ plans capital raise to support "ambitious" scale-up |
| 14/11/2024 | 07:00 | UK RNS | HeiQ PLC Update on Delisting and Potential Capital Raise |
| 31/10/2024 | 07:01 | UK RNS | HeiQ PLC Notice of AGM |
| 31/10/2024 | 07:00 | UK RNS | HeiQ PLC Results for 18-month period ended 30 June 2024 |
| 24/10/2024 | 10:26 | UK RNS | HeiQ PLC Holding(s) in Company |
| 22/10/2024 | 06:00 | UK RNS | HeiQ PLC Restructuring and Delisting |
| 18/9/2024 | 10:45 | UK RNS | HeiQ PLC Holding(s) in Company |
| 16/9/2024 | 08:03 | UK RNS | HeiQ PLC Director/PDMR Shareholding |
Heiq (HEIQ) Share Charts1 Year Heiq Chart |
|
1 Month Heiq Chart |
Intraday Heiq Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 09/12/2024 | 22:43 | Super Textile With Impressive Potential | 604 |
| 18/11/2024 | 11:52 | HeiQ - interesting articles | 23 |
| 18/11/2024 | 11:49 | Heiq with all information | 317 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 10/12/2024 08:20 by Heiq Daily Update Heiq Plc is listed in the Finance Services sector of the London Stock Exchange with ticker HEIQ. The last closing price for Heiq was 4.50p.Heiq currently has 168,540,000 shares in issue. The market capitalisation of Heiq is £7,584,300. Heiq has a price to earnings ratio (PE ratio) of -0.36. This morning HEIQ shares opened at - |
Posted at 14/11/2024 11:45 by hedgehog 100 14/11/2024 07:00 RNS Regulatory News HeiQ PLC Update on Delisting and Potential Capital Raise LSE:HEIQ Heiq Plc"Further to the announcement on 22 October 2024 regarding HeiQ Plc's delisting from the London Stock Exchange ("LSE"), the Company wishes to update shareholders on the next steps following its scheduled delisting on 19th November 2024. Last trading day at LSE As it is anticipated that the delisting will become effective at 08:00 a.m. (GMT) on 19 November, 2024, the last effective trading day of HeiQ Plc shares ('Ordinary Shares') on the LSE will be Monday 18 November 2024. Strengthening of financial foundation by means of a capital raise In alignment with our strategic restructuring and ongoing efforts to reposition the Company for long-term growth, HeiQ is currently preparing for a capital raise in the coming weeks via an open offer to all current shareholders. This anticipated capital raise is designed to strengthen HeiQ's financial foundation and support our ambitious venture scale-up plans to deliver value to all stakeholders. Therefore, HeiQ has initiated discussions with selected independent investors who have expressed interest in supporting the Company during this transition and beyond. It is anticipated that a number of investors will formally underwrite the capital raise, providing assurance and confidence in our strategy. Further details regarding the capital raise and open offer terms will be provided to shareholders in due course as we progress toward finalizing these arrangements. The Board remains committed to ensuring that all shareholders are afforded an opportunity to participate in the Company's future. Secondary trading post-delisting The Company has now appointed Asset Match (www.assetmatch.com) to facilitate trading in the Ordinary Shares following delisting. Asset Match, a firm authorized and regulated by the Financial Conduct Authority (FRN 579310), will operate an electronic off-market dealing facility for the Ordinary Shares. This facility will allow existing holders of Ordinary Shares in the Company ("Shareholders") and new investors to trade Ordinary Shares by matching buyers and sellers through periodic auctions. Investors are encouraged to register on www.assetmatch.com and add HeiQ to their 'Watchlist' to continue to receive Company updates and auction/price information. Please note the HeiQ page on the Asset Match website will go live on 19 November 2024, while the investor page on HeiQs website will reflect the private status of HeiQ going forward. The Asset Match trading facility operates under its own code of practice which governs the behaviour of participants and the running of the periodic auctions. Asset Match operates an open auction system where volumes of bids and offers at different prices are displayed on its website together with the closing date of the auction. At the end of each auction period, Asset Match passes this information through a non-discretionary algorithm that determines a "market-derived" share price based on supply and demand and allocates transactions accordingly. Bids and offers may be made and withdrawn at any time before the closing date of each auction. Shareholders will continue to be able to hold their shares in uncertificated form (i.e. in CREST) and should check with their existing stockbroker whether they are willing or able to trade in unquoted shares. Shareholders wishing to trade shares through Asset Match must do so through a stockbroker. A comprehensive list of stockbrokers who have signed up to access the Asset Match platform is available on request. Shareholders may contact Asset Match in relation to any queries regarding trading via the secondary market trading facility by emailing dealing@assetmatch.c The Board would like to thank shareholders for their continued support and will provide additional updates as appropriate. For further information, please contact: Rita Brandao investors@heiq.com" Note that as at 30.6.24, HEIQ had net debt of US$13.5M., which will now be significantly higher:- 31/10/2024 07:00 RNS Regulatory News HeiQ PLC Results for 18-month period ended 30 June 2024 LSE:HEIQ Heiq Plc " ... Cash at 30 June 2024 of US$5.0 million with net debt (including lease liabilities) of US$13.4 million ..." This needs to be added to HEIQ's market cap. of £6.74M. at 4p/share, to give the enterprise value: probably somewhere in the region of c. £20M. And if that e.v. is reduced by c. a quarter, it could reduce the market cap. by c. three quarters, to c. a penny per share. "What Is Enterprise Value (EV)? Enterprise value (EV) measures a company’s total value. Its calculation includes not only the market capitalization of a company but also short-term and long-term debt, as well as any cash or cash equivalents on the company’s balance sheet. It is often used as a more comprehensive alternative to market capitalization when valuing a company." |
Posted at 22/10/2024 14:57 by hedgehog 100 22/10/2024 07:00 RNS Regulatory News HeiQ PLC Restructuring and Delisting LSE:HEIQ Heiq Plc" ... As a company listed on the equity shares (transition) category, the Company is not required to obtain the approval of shareholders for the Delisting but is required under UK Listing Rule 21.2.17 to give at least 20 business days' notice of the intended cancellation. Accordingly, HeiQ has requested that (i) the FCA cancel the listing of the Shares on the Official List of the FCA, and that (ii) the LSE cancels the admission to trading of the Shares on the Main Market for listed securities of the LSE. ..." So HEIQ is actually main-listed, not AIM-listed, which shows that this is no defence against this sort of thing. Indeed, unlike if it was on AIM, HEIQ doesn't need shareholders approval at a GM for the delisting: which isn't always a done deal, as 75% of the votes cast must be in favour of the delisting. |
Posted at 22/10/2024 10:28 by hedgehog 100 Catabrit 12 Sep '24 - 08:16 - 284 of 298 0 4 1"Sadly, the writing has been on the wall for quite some time. I suspect they will eventually delist." 22/10/2024 07:00 RNS Regulatory News HeiQ PLC Restructuring and Delisting LSE:HEIQ Heiq Plc Well done Catabrit. |
Posted at 13/8/2024 09:21 by tvh123 Textile Technlogy have fudged up with the title - funding is being sought, and hasn't been secured.HeiQ AeoniQ have publised a Series A investor presentation on their website: hxxps://www.heiq.com |
Posted at 06/8/2024 11:55 by bad gateway Trending as Textile Technology's most read article. No idea where they're getting their info from but interesting all the same..Investment secured for sustainable fiber technology HeiQ AeoniQ Tuesday, 06. August 2024 Focus on sustainable dyeing technologies HeiQ reported about another round of capital investment destined for their sustainable fiber technology, HeiQ AeoniQ. This high-performance cellulose yarn is based on a new fiber derived from carbon negative materials. It is positioned to potentially substitute synthetic filament yarns. This moves towards equity financing underlines the company's dedication towards advancing environmentally friendly textile production and reducing dependency on potentially harmful oil-based fabric materials. This additional funding plays a vital role in amplifying production volumes and will contribute to the establishment of the first large-scale industrial factory in Maia/Portugal, which is slated to start operations in 2026. The Portuguese government has recognized this investment as a project of national importance (PIN status), and it is predicted to attract a generous grant package from public institutions. Launch of innovative sneakers using HeiQ AeoniQ The apparel manufacturer Hugo Boss AG, Metzingen/Germany, has recently unveiled "The Change Sneakers", a new addition to their platform that continues to shape the course of sustainable fashion. These innovative sneakers are made with the cellulosic filament yarn HeiQ AeoniQ of HeiQ AeoniQ Holding AG, Zurich/Switzerland. This fiber is designed to replace oil-based filament yarns such as polyester and polyamide, effectively reducing reliance on fossil fuels. The upper part of the sneakers is composed of 85% HeiQ AeoniQ, ensuring the footwear is comfortable and durable. Additionally, the shoe's laces and labels are wholly crafted from cellulosic HeiQ AeoniQ yarn. This diversification into new applications with products like the Boss "The Change Sneakers" illustrates the versatility of the sustainable fiber HeiQ AeoniQ. HeiQ AeoniQ = registered trademark |
Posted at 02/7/2024 07:33 by bad gateway Didn't mark you down so can't help there but re sustainability heiq still believes it is.."HeiQ AeoniQ™ can be manufactured from different cellulosic raw materials such as Circulose®, bacterial cellulose and non-valorized agricultural waste. The production process is so flexible that the final HeiQ AeoniQ™ properties can be tuned to match those of synthetic materials like polyester or nylon. HeiQ AeoniQ™ yarns are designed for cradle-to-cradle circularity and can be recycled repeatedly while maintaining consistent fiber quality." Circulose is renewcell mark2. |
Posted at 06/11/2023 14:09 by hedgehog 100 30/10/2023 07:01 UK Regulatory (RNS & others) HeiQ PLC Interim Results LSE:HEIQ Heiq Plc"Half year results for the period ended 30 June 2023 ... Financial Overview: -- Revenue reduced by 26% to US$20.5 million (H1 2022 restated*: US$27.6 million) -- Gross profit margin of 40.9% (H1 2022 restated*: 41.5% in H1 2022) -- Adjusted EBITDA of US-$3.6 million (H1 2022 restated*: US$0.7 million) -- Operating loss of US-$6.0 million (H1 2022 restated*: US-$1.6 million) -- Loss after taxation of US$-6.5 million (H1 2022 restated*: profit of US-$1.9 million) -- Cash balance as at 30 June 2023 of US$7.3 million * Details on restatements of prior year financial information are disclosed in Note 2 of t he Consolidated Financial Statements. Operational Overview: Trading conditions for the markets of our commercialized product range continued to be challenging during H1 2023 and, as highlighted in detail in our Full Year results for the 12 months to 31 December 2022, the Company took decisive steps to reduce its cost base and reorganize the business to maintain its innovation and differentiation capabilities during the period under review. With costs reduced and operations adapted in light of the challenging headwinds our entire industry is facing, the Company expects H2 2023 trading to stabilize ... Liquidity as of 30 June 2023 & Going Concern Assessment As of June 30, 2023, the Company reports a cash balance of US$7.3 million (December 31, 2022: US$8.5 million). To manage its cash balance, the Group has access to credit facilities totalling CHF9.0 million (approximately US$9.8 million as of September 30, 2023). The credit facilities are in place with two different banks and both contracts have materially the same conditions. The facilities are not limited in time, can be terminated by either party at any time and allow overdrafts and fixed cash advances with a duration of up to twelve months. As of September 30, 2023, the Group has drawn CHF6.3 million of the facilities (CHF2.4 million as of December 31, 2022) (see Note 2 for details including maturity dates). The facilities are not committed, but the Board has not received any indication from financing partners that facilities are at risk of being terminated. Furthermore, the Board is in discussions with financial institutions to replace the currently uncommitted credit facilities by committed, long-term facilities, but the outcome of these discussions remains uncertain. The Group's directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future and operate within its credit facilities for the period 12 months from date of signature. Nevertheless, the Board acknowledges the uncommitted status of the facilities which could be terminated requiring the refinancing of debts, and which casts material uncertainty on the going concern assessment until appropriate longer-term funding is in place. Further disclosures on the going concern assessment are made in the notes to the financial statements. ..." So HEIQ expects H2 trading to "stabilize". I take that to mean that they expect it to be similar to H1, as opposed to getting worse. Though this is still just an expectation, two thirds of the way through this period. And this is despite having reduced costs in H1. Other things being equal, such stabilisation would suggest a H1 operating loss of c. US$6M., like H1. Cash at 30.6.23 was US$7.3M., but this is balanced out by the short-term borrowings of US$7.47M. at 30.6.23. HEIQ has CHF9.0 million (equating to c. US$9.8 million as at 30.9.23) of (discretionary) credit facilities, but as at 30.9.23 had drawn down 70% of these, with just CHF2.7 million left, having drawn down CHF3.9 million in the first 9 months of this year, an average drawdown rate of CHF1.3 million per quarter. So at this rate of drawdown the facility would be exhausted by early April 2024. That seems incongruous with the company's indication that funds should last until late October next year. In order to last that long, with no additional injection of funds, you would think that trading would have to improve significantly ... whereas the company is only expecting stabilisation. Replacement of the short-term credit facility with a long-term facility of the same size wouldn't actually provide more money. So the bottom line is that the company looks to be running out of money, and has a bad track record of misleading investors with its forecasts. A big placing looks to be the most likely outcome, probably within the next few/several months. And in the current very bad fundraising environment for loss-making companies like this, that is likely to be at a lot less than the current share price of 20p. That I believe is why HEIQ's CEO hasn't bought shares since the company's return from suspension, despite coming out of the close period: he's 'keeping his powder dry' for a forthcoming discounted placing. And if he apparently doesn't have confidence in the current s.p., despite the big drop since his buys in January at 28p average & 34p, then why should anyone else? |
Posted at 29/6/2023 09:11 by catabrit I’m not sure it’s entirely fair to blame management here. I mean a bunch of you bought this thing at quite a punchy price and unfortunately that leaves little margin for error.They’re aligned with us via their shareholdings and I’m sure the suspension and drop in share price is frustrating, let alone embarrassing, for Carlo and the rest of the management team. There have been signs of a wider downturn or potential deterioration in consumer sentiment for quite some time. If the management team are at fault here, it’s in not preparing for that or doing enough “what if” analysis from both an operating and shareholder perspective. But that’s easier said than done, especially when your currency (share price) is riding high and gives you firepower to expand the business. I think the team will pull every lever they can to avoid an equity raise. We can’t rule one out, but I feel it unlikely. They’ll just cut overhead and dial back some of their growth plans. We still have a lot of optionality here because of the claim, AeoniQ and the graphene business. Unless Carlo has grossly overpaid, I’m pretty sure that the businesses he’s acquired since the IPO roughly total the current market cap (there or thereabouts). We probably need to haircut those but still, add up the various bits and pieces and the discount is pretty meaningful. Unlike a lot of businesses in this situation (over-levered, wrong side of secular trends) we’re in good shape. The issue here is the great expectations that were baked into the share price. It will take time to restore trust and credibility but I don’t see anything that’s terminal. I could be wrong and that’s the game and so I look forward to receiving the annual report and commentary and what happens to the share price when trading resumes. |
Posted at 29/4/2023 13:30 by hedgehog 100 This has certainly been one to forget about for holders so far!But of course if the company's results recover, then the share price should do likewise. Anyone considering a HEIQ buy after the return from suspension may be interested in this research:- "What to do when one of your stocks warns on profit We discuss how share prices react in the aftermath of a profit alert 06 June 2019|Feature ... RECOVERY FROM A WARNING DEPENDS ON CIRCUMSTANCES A study by UK finance professors George Bulkley, Richard Harris and Renata Herrerias looked at 455 profit warnings issued between 1997 and 1999 and tracked the stocks until 2001. Unlike some of the other studies that we discussed, this study looked further ahead. It tracked future earnings announcements that were released to the market. It found that between 12 and 24 months after a profit warning, the average cumulated excess daily returns of these stocks was a positive 23% relative to the market. In other words, the stocks showed strong signs of recovery between one and two years after the warning. This can be explained by analysts being slow to change their opinions, even in the face of new information. ..." The period of a year gives sufficient time for the share price to deflate, and for business recovery to take place and be sufficiently reported. And it's also partly psychological: the one year period gives sufficient time for 'emotional healing'; and there's an element of 'self-fulfilling prophecy' re standard expectations of the common time period before recovery. A good recent example of this 'one year rule' working well is NWT (Newmark Security). After its 15th. October 2021 trading update the company's share price nearly halved over the following twelve months. But since its 27th. October 2022 trading update, its share price has more than doubled (from 25.5p to 56.5p), on improved trading. "Newmark Security in 2023: A Transformed Tech & USA Success Story" Newmark Security (NWT):- |
Posted at 03/3/2021 07:10 by jammytass 3 March 2021HeiQ Plc ( Acquisition of 51% of Industrial Biotech Business, Chrisal HeiQ Plc (LSE:HEIQ), an established global brand in materials and textile innovation which operates in high-growth markets, is pleased to announce that it has signed an agreement to acquire 51% of the share capital and voting rights of Chrisal N.V., Belgium ("Chrisal", "the Acquisition"). The Acquisition is for a consideration of €7.5 million, with €5.0 million payable in cash and €2.5 million through the issue of 1,101,928 new ordinary shares by HeiQ. On completion, Chrisal will be renamed HeiQ Chrisal. Chrisal is a profitable industrial biotechnology company and a leader in innovative ingredients and consumer products that incorporate the benefits of probiotics and synbiotics. It has 120 products within its three technology platforms that create healthy and sustainable microbial ecosystems. The application of its proprietary technology includes cosmetics, personal care, textiles, wound dressings, water purification, air treatment and cleaning products. Chrisal has recently developed a synbiotic interior cleaner, Synbio®, for healthcare and hospitals, a project sponsored by The Gates Foundation. Early results have indicated Synbio® cleaners to be equal to disinfectants and detergents but without bacterial resistance downsides, while offering enhanced cleaning performance. The Acquisition is aligned with HeiQ's strategy of becoming a global leader in materials innovation. It also solidifies HeiQ's position as a profitable and fast-growing pioneer in the $24 billion global textile chemicals market. HeiQ already directly serves the $10 billion antimicrobial textile market with its HeiQ Viroblock and HeiQ Pure technology platforms and the Acquisition will strengthen its presence with a complementary probiotic platform while enabling it to enter the new adjacent and lucrative markets of surface hygiene treatment, water purification and probiotic personal care. Additional Highlights · Chrisal recorded revenue of €5.5 million for the 12 months to 31 December 2020, an increase of 62% compared to 2019, and an operating profit of €1.6 million (28.9%) - unaudited. · Chrisal has over 500 commercial customers in 25 countries, including hospitals, food and cosmetic manufacturers, presenting HeiQ with compelling cross-selling opportunities for its existing core product range. Chrisal will benefit from HeiQ's extensive customer and distribution network, as well as its marketing prowess. · Chrisal customers include Q viva, Ahava, Atena-Alfa, Probilife, Sonax, Woellner and Greenspeed · The Acquisition includes a bottling facility in Belgium. This is an important infrastructure requirement for HeiQ's ambitions in functional textile aftercare and other fields. · The current Chrisal President and Founder Corrie Gielen and its CEO/CTO Dr. Robin Temmerman will continue to lead the business, supported by the existing Chrisal team. · HeiQ co-Founder and Group CEO Carlo Centonze as well as Group CFO Xaver Hangartner will join the HeiQ Chrisal Board of Directors and will explore further synergies over the course of 2021. · HeiQ Chrisal will be responsible for the creation, production and commercialisation of its products, with HeiQ acting as its corporate service hub and extended commercialization arm. · Chrisal's patented technology carries the prestigious EU Ecolabel, a label of excellence that is awarded solely to products meeting high environmental standards throughout their lifecycle. HeiQ co-founder and CEO Carlo Centonze said: "The acquisition of a majority stake in Chrisal brings multiple benefits to HeiQ and its shareholders. HeiQ Chrisal will provide us with revenue from other fast-growth markets adjacent to those we serve already, as well as exciting cross-selling opportunities for our and their existing core product range. The acquisition will progress our direct to consumer offer and enlarges our product offering to hygiene-sensitive environments, such as the healthcare sector. "Chrisal's technology platform includes an anti-allergen effect for mattresses and bedding, microbial and viral protection for surfaces, anti-inflammatory effects in wound dressings, probiotic skin enhancing cosmetics, algae and biofilm control in drinking water as well as advanced synbiotic protection to replace the resistance-creating antibiotics in animal husbandry. We are particularly excited about Chrisal's synbiotic technology solution for healthcare and hospitals for which full clinical results are due to be published imminently in a leading journal. "HeiQ is increasingly becoming more than a textile technology company; we are innovating materials more broadly. This acquisition of a leading probiotics business is aimed at making HeiQ a leader in probiotic innovation, positioning us well to serve many lucrative segments of this fast growth USD 50 billion market. "Chrisal's culture of entrepreneurship, people empowerment, sustainability, innovation and lean processes are a perfect match with HeiQ. I expect this partnership to become a great success and we will look forward to working closely with Corrie, Robin and the rest of the Chrisal team." Corrie Gielen, President of Chrisal commented: "For 30 years Chrisal has built on new technologies to improve our world in a sustainable way. With our latest patented Synbio® technology we have found the best solution to strengthen products, people and our environment. We are confident that the new partnership with HeiQ will bring us the additional competences and network needed to globalize this beautiful and groundbreaking technology. Together we combine the best of nature with the latest in science to make the difference for a better world." Further Information on Chrisal: Chrisal is an industrial biotechnology leader in prebiotic, probiotic and synbiotic technologies and products. With its 120 products, Chrisal serves commercial and consumer customers operating in the markets of cosmetics, personal care, textiles, wound dressings, water and air purification and cleaning solutions for hospitals and animal husbandry. Early results from clinical trials for Chrisal's patented Synbio®, an active synbiotic surface cleaner, suggest that it could be the next generation technology to probiotic surface cleaners, such as Reckitt Benckiser's VEO. Chrisal technology carries the prestigious EU Ecolabel, a label of environmental excellence that is awarded solely to products meeting high environmental standards throughout their lifecycle. The industrial biotech acquisition will provide HeiQ access to the technology platform of prebiotics, probiotics and postbiotics for bio-based odor & stain control for carpet & footwear, anti-allergen effect in mattress and bedding, microbial and viral protection for surfaces, anti-inflammatory effect in wound dressings, probiotic skin enhancing cosmetics, algae and biofilm control in drinking water as well as advanced synbiotic protection replacing the resistance-creating antibiotics in animal husbandry. With this strategic acquisition HeiQ enters the broader market of surface management and accesses a bio-based green complementary technology platform to its antimicrobials. Chrisal's 120 products strengthen HeiQ's global product offering and will facilitate HeiQ's existing technology platforms into new markets. Chrisal has a large, efficient manufacturing footprint in Lommel, Belgium and brings into the HeiQ group the strategic capability of bottling, a step required for HeiQ's B2C products ambitions in functional textile aftercare and other fields. Chrisal also includes a microbiology and molecular diagnostics lab for R&D and QC activities. HeiQ Chrisal, the new corporate name for Chrisal, will continue to be led by President and Founder Corrie Gielen, its CEO/CTO Dr. Robin Temmerman as well as the entire Chrisal team. The entrepreneurial drive will be strengthened by HeiQ's Group support functions in Rapid & Deep R&D, Branding & Marketing, Regulatory and Compliance as well as Commercialisation. HeiQ co-Founder and Group CEO Carlo Centonze as well as Group CFO Xaver Hangartner will join the HeiQ Chrisal Board of Directors. HeiQ Chrisal will be responsible for the creation, production and commercialization of its products, with the HeiQ Group acting as its corporate service hub and extended commercialization arm. Together, the newly enlarged Board will explore further synergies over the course of 2021. Issue of Equity and Total Voting Rights The Company will issue 1,101,928 new ordinary shares ("Consideration Shares") to the sellers of Chrisal, at a price of 1.9596p per share, which is the average 5 day closing price prior to signing, in order to part satisfy the consideration due. Applications will be made for the Consideration Shares to be admitted to the standard segment of the Official List, and to trading on the London Stock Exchange's Main Market ("Admission"). It is expected that Admission will become effective, and that dealings in the new Ordinary Shares are expected to commence, at 8.00 a.m. on 9 March 2021. Following Admission, the total number of Ordinary Shares in issue will be 126'993'832 and the total number of voting rights will therefore be 126'993'832. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules. This announcement contains inside information. For further information, please contact: HeiQ Plc |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
